Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2016 Aug 24;6:32045. doi: 10.1038/srep32045

Pulsed electromagnetic fields promote osteogenesis and osseointegration of porous titanium implants in bone defect repair through a Wnt/β-catenin signaling-associated mechanism

Da Jing 1,*, Mingming Zhai 1,*, Shichao Tong 1, Fei Xu 2, Jing Cai 3, Guanghao Shen 1, Yan Wu 4, Xiaokang Li 4, Kangning Xie 1, Juan Liu 1, Qiaoling Xu 5,a, Erping Luo 1,b
PMCID: PMC4995433  PMID: 27555216

Abstract

Treatment of osseous defects remains a formidable clinical challenge. Porous titanium alloys (pTi) have been emerging as ideal endosseous implants due to the excellent biocompatibility and structural properties, whereas inadequate osseointegration poses risks for unreliable long-term implant stability. Substantial evidence indicates that pulsed electromagnetic fields (PEMF), as a safe noninvasive method, inhibit osteopenia/osteoporosis experimentally and clinically. We herein investigated the efficiency and potential mechanisms of PEMF on osteogenesis and osseointegration of pTi in vitro and in vivo. We demonstrate that PEMF enhanced cellular attachment and proliferation, and induced well-organized cytoskeleton for in vitro osteoblasts seeded in pTi. PEMF promoted gene expressions in Runx2, OSX, COL-1 and Wnt/β-catenin signaling. PEMF-stimulated group exhibited higher Runx2, Wnt1, Lrp6 and β-catenin protein expressions. In vivo results via μCT and histomorphometry show that 6-week and 12-week PEMF promoted osteogenesis, bone ingrowth and bone formation rate of pTi in rabbit femoral bone defect. PEMF promoted femoral gene expressions of Runx2, BMP2, OCN and Wnt/β-catenin signaling. Together, we demonstrate that PEMF improve osteogenesis and osseointegration of pTi by promoting skeletal anabolic activities through a Wnt/β-catenin signaling-associated mechanism. PEMF might become a promising biophysical modality for enhancing the repair efficiency and quality of pTi in bone defect.

Bone defects resulting from trauma, non-union fractures or osteo-degenerative diseases are common and challenging clinical issues. Application of bone grafts to improve bone healing is a major therapy for bone defect, especially for the critically sized defect that the endogenous bone regeneration is inadequate to repair the damaged tissues1. Clinically, autograft and allograft are regarded to be the major grafting procedures for the surgeons due to their excellent osteoinductive and osteogenic properties2. However, significant limitations exist regarding the tissue availability and donor site morbidity for the autograft3. Moreover, the autograft has the risk of being absorbed at the implantation site. Allograft also possesses some drawbacks, such as the immunological rejection and requirement of intense logistic efforts due to limited tissue availability4. Thus, it is of great clinical significance to develop safe and economic alternative grafting materials for the repair of bone defect.

Titanium alloys have been extensively recognized as ideal endosseous implants because of their excellent mechanical properties, biocompatibility and corrosion resistance. However, the mismatch in the mechanical strength between metallic implants and surrounding natural bone can cause the stress-shielding effect and accelerate bone resorption, and thus increase the risk of implant loosening5. Recently developed titanium-based alloys with porous structure were able to effectively decrease the mismatch of elastic modulus between implants and bone tissues6,7. Moreover, the internal porosity forms interconnected pore channels for the transport of nutrient and metabolites6,8. However, it should be noted that titanium alloys, as bioinert materials, can be easily connected with bones in the form of mechanical interlock rather than chemical bonding5,8,9. Thus, titanium alloys even at porous structure are impossible to achieve adequate osseointegration as the nature bone, which is regarded as a major clinical limitation for not providing early fixation with reliable long-term stability as bone substitutes, especially for the osteoporotic patients10,11. Therefore, developing novel technique that can promote the bone ingrowth through the pores and speed up osseointegration processes of porous titanium alloys (pTi) holds great significance for increasing the efficiency and success rate of the repair of bone defect.

In the past four decades, substantial and growing evidence has shown that pulsed electromagnetic fields (PEMF) therapy as an alternative noninvasive method is capable of producing satisfying therapeutic effects on a wide range of bone diseases, such as fresh and nonunion fractures and osteoarthritis12,13,14. Several in vivo investigations have also demonstrated that PEMF stimulation could inhibit bone loss and improve bone quality in various osteoporotic animals15,16,17,18,19,20. The anti-osteoporotic efficiency of PEMF was further confirmed by several clinical investigations21,22. PEMF stimulation has been shown to promote proliferation and mineralization of osteoblasts in vitro and also inhibit osteoclastogenesis23,24,25,26. Investigations by our group and others have also demonstrated that PEMF stimulation was able to promote osteoblast functions in vitro and accelerate bone formation in vivo onside pure titanium surface27,28,29,30,31. However, we still lack critical knowledge regarding whether PEMF can promote the biocompatibility of bone cells with titanium implants with porous structure and accelerate osteogenesis and osseointegration of pTi in bone defect repair, which may have more significant clinical therapeutic significance. Moreover, the potential mechanisms by which PEMF regulate osteogenesis and osseointegration of pTi also remain poorly understood.

In the present study, the potential effects of PEMF stimulation on the biological performance of pTi were systematically evaluated both in vitro and in vivo. First, we investigated the impacts and underlying mechanisms of PEMF on in vitro osteoblast activities and functions in pTi. Then, the promotional effects of PEMF stimulation on the repair of bone defect by pTi implants were systematically evaluated via analyses for histological and histomorphometric parameters. Furthermore, the molecular signaling pathway mechanisms of PEMF on in vivo osteogenesis in pTi implants were also investigated.

Materials and Methods

Preparation of pTi implants

The porous Ti6Al4V implants with 70% porosity and 750 μm pore size were designed using the computer-aided design (CAD) software and fabricated using the electron beam melting system (EBM S12, Acram AB, Sweden) according to our previously described protocol7. All implants were sterilized with an autoclave at 121 °C with the pressure of 103 kPa for 2 h before use. The prepared pTi implant was scanned with micro-computed tomography (μCT, Y. Cheetah, YXLON, Germany) and scanning electron microscope (SEM, JSM-6460, JEOL, Japan) for visualizing its microstructure and morphology, respectively.

PEMF stimulators

As described in our previous studies18,19,20,32, the PEMF waveform used in the present in vitro or in vivo experiment consisted of a pulsed burst (burst width, 5 ms; pulse width, 0.2 ms; pulse wait, 0.02 ms; burst wait, 60 ms; pulse rise, 0.3 μs; pulse fall, 2.0 μs) repeated at 15 Hz (Fig. 1). This PEMF waveform has shown the efficiency on inhibiting bone loss induced by disuse, estrogen deficiency and type-1 diabetes in rats in our previous study18,19,20,32. The PEMF exposure system was composed of a signal generator and a Helmholtz coil assembly with three-coil array (Fig. 1). For the in vivo study, the three coils (80 cm diameter) were placed coaxially with 30.4 cm apart from each other, and the numbers of turns of the central coil and outside coils were 266 turns and 500 turns, respectively. The bottom of the plastic rabbit cage was aligned with the center of the coils to ensure that the rabbits were confined in the center of the electromagnetic fields. For the in vitro experiment, the interval distance between three coils (20 cm diameter) were 7.6 cm, and the turn numbers of the central coil and outside coils were 53 and 100, respectively. The assembly of three coils has been proved to exhibit significantly upgraded axial magnetic field uniformity and also show significantly decreased deviation of the magnetic field between the origin and any other off-axial point within the coils19,33. To calculate the current in the coils, a resistor of 2 Ω was placed in series with the coils and the voltage drop across the resistor was observed with an oscilloscope (Agilent Technologies, Santa Clara, CA, USA). The peak magnetic field of the coils was determined to be approximately 2.0 mT. The accuracy for the peak magnetic field measurement was further confirmed by using a Gaussmeter (Model 455 DSP, Lake Shore Cryotronics, Westerville, OH, USA). The measured background electromagnetic field was 50 ± 2 μT. In order to determine the induced electric field within the coils, a custom-designed electrical potential detecting circular coil (5 cm coil diameter, 1 mm coil diameter, 20 turns) was placed in the midcenter of the Helmholtz coils with the coil parallel to the Helmholtz coils. The current detecting coil was connected with the oscilloscope, and the induced peak electrical field was determined to be approximately 2 mV/cm.

Figure 1. Characterization of pTi samples, PEMF system setups and in vivo experiment protocol.

Figure 1

Open in a new tab

(A) Gross view and μCT scanning of pTi samples for in vitro and in vivo experiments. (B) Microstructural observation of pTi implants via SEM scanning. (C) Surgical photograph showing the cylindrical bone defect with 6.0 mm diameter and 8.0 mm length created in the femoral lateral condyle. A pTi implant was then transplanted into the bone defect sites and the accuracy of the defect location was further confirmed via X-ray scanning. (D) Schematic representation of the PEMF generator together with a Helmholtz coil assembly with three-coil array. The PEMF output waveform consisted of a pulsed burst (burst width, 5 ms; pulse width, 0.2 ms; pulse wait, 0.02 ms; burst wait, 60 ms; pulse rise, 0.3 μs; pulse fall, 2.0 μs) repeated at 15 Hz. The peak magnetic field within the Helmholtz coils was approximately 2.0 mT. (E) The experimental protocols for the present in vivo investigation.

Cell culture

Osteoblast-like MC3T3-E1 cells (a cell line from C57BL/6 mouse calvaria) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were maintained in α-Minimum Essential Medium (α-MEM, Hyclone, Logan, UT, USA) containing 10% fetal bovine serum (FBS, Hyclone) and 1% penicillin/streptomycin (Gibco, Carlsbad, CA, USA) in a water-saturated atmosphere of 5% CO2 at 37 °C. The α-MEM cell culture medium contained both ascorbic acid and sodium phosphate, which were important for MC3T3-E1 cells to maintain osteoblast-like phenotype. Cells were seeded into the pTi implants (12.0 mm diameter and 2.5 mm thickness) at a density of 5 × 104 cells/ml for 12 h. Then, cells in the PEMF group were subjected to 2 h/day PEMF stimulation for 3 days. In the Control group, cells were placed within the inactivated Helmholtz coils to exhibit sham PEMF exposure.

In vitro osteoblast attachment, morphology and proliferation

To evaluate the cell attachment and morphology, MC3T3-E1 cells after PEMF or sham exposure were fixed in 4% formaldehyde solution for 5 min and then permeabilized with 0.1% Triton X-100. Cells were stained with 50 mg/ml FITC (Sigma, St. Louis, MO, USA) for 40 min followed by 40,60-diamidino-2-phenylindole (DAPI, Beyotime Institute of Biotechnology, Jiangsu, China) staining for 5 min. Cells were then imaged and analyzed under a confocal microscope (FV1000, Olympus, Tokyo, Japan) in five randomly selected fields of view. For determining the cell proliferation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) assays were performed. In brief, the pTi samples seeded with MC3T3-E1 cells were incubated with 80 μL MTT at 37 °C for 4 h. Then, 800 μL dimethyl sulfoxide (DMSO) was added to dissolve the formazan formed by MTT. The mixture was then transferred to 96 well plate and the optical density (OD) values were determined at 490 nm with a multimode microplate reader (Tecan GENios. San Jose, CA, USA).

In vitro osteogenesis-related gene expressions in osteoblasts

Total RNA was isolated from the MC3T3-E1 cells attached to the implants using TRizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol and quantified using a spectrophotometry (SmartSpec Plus, Bio-Rad, Hercules, CA, USA). 2 μg RNA was reverse-transcribed into cDNA in 40 μL system with oligo(dT)18 as a primer using FastQuant RT Kit (Tiangen Biotech, Beijing, China). RT-PCR was performed on 2 μL cDNA in a reaction of 20 μL system with Maxima SYBR Green qPCR (Thermo Fisher Scientific, Waltham, MA, USA) using the Bio-Rad CFX96 real-time PCR detection system (Philadelphia, PA, USA). The primer sequences utilized in semi-quantitative RT-PCR are shown in Table 1. The protocol for semi-quantitative RT-PCR reactions consisted of an initial denaturation at 95 °C for 10 min followed by 40 cycle denaturation at 95 °C for 15 sec, annealing at 55 °C for 15 sec, and extension at 55 °C for 15 sec. β-Actin was used as an internal control for normalization. The relative quantity of mRNA was calculated (2−△△Ct analysis).

Table 1. The sequence of primers used in the present study for in vitro real-time fluorescence quantitative PCR.

Genes Primers Primer Sequence (5′-3′) Product Length (bp)
Runx-2 Forward TGCACCTACCAGCCTCACCATAC 105
Reverse GACAGCGACTTCATTCGACTTCC
Osx Forward TATGGCTCGTGGTACAAG 200
Reverse TCAGATGGGTAAGTAGGC
COL-1 Forward GAAGGCTGGAGAGCGAG 132
Reverse CGGGACCTTGTTCACCTC
Wnt1 Forward ATTTTGGTCGCCTCTTTG 140
Reverse GTGGCATTTGCACTCTTG
Lrp6 Forward CAGCACCACAGGCCACCAA 227
Reverse TCGAGACATTCCTGGAAGAG
β-catenin Forward GGAAAGCAAGCTCATCATTCT 171
Reverse AGTGCCTGCATCCCACCA
β-Actin Forward GCCAACACAGTGCTGTCT 114
Reverse AGGAGCAATGATCTTGATCTT
Open in a new tab

In vitro osteogenesis-related protein expressions in osteoblasts

The MC3T3-E1 cells attached to the implants were washed with ice-cold PBS and lysed to release the whole proteins by RIPA buffer with 1 mM PMSF. The cell lysates were transferred into a pre-cooled microfuge tube and agitated for 30 min at 4 °C. The protein extracts were then centrifuged at 4 °C for 20 min. The protein content of the supernatant was collected and the protein concentration was determined by the BCA assay using a BCA protein assay kit (Pierce Chemical, Rockford, IL). The protein extracts (30 μg per sample) were subjected to electrophoretic separation by 10% Tris-glycine SDS-PAGE and transferred onto PVDF membranes (Millipore) after mixed with 2× loading buffer and boiled for 5 min. The PVDF membranes were blocked in TBST (Tris Buffer Saline, 0.5% Tween-20) containing 5% BSA for 1 h and incubated overnight at 4 °C with primary antibodies to Runx2 (1 × 10−3 mg/ml), Wnt1 (1 × 10−3 mg/ml), Lrp6 (0.5 × 10−3 mg/ml), β-catenin (0.2 × 10−3 mg/ml), β-Tubulin (1 × 10−3 mg/ml), and β-Actin (1 × 10−3 mg/ml) in TBST containing 5% BSA. All primary antibodies were purchased from Abcam (Cambridge, MA, USA). The membranes were then incubated with a 1:3000 dilution of HRP-conjugated goat anti-rabbit secondary antibody (Bioworld Technology, Minneapolis, MN, USA) for 1 h, and then visualized by an ECL chemiluminescence system (ImageQuant 350, GE Healthcare, Piscataway, NJ, USA). Semi-quantitative analysis was performed using the QuantityOne Software (Bio-Rad, Hercules, CA, USA). β-Tubulin or β-Actin was used as the internal control for normalization.

Bone defect animal model

All procedures in the experiment were approved by the Institutional Animal Care and Use Committee of the Fourth Military Medical University, and all procedures were strictly carried out in accordance with the approved guidelines. Twenty-four female New Zealand rabbits with 14.5 ± 2.3 weeks of age weighting 2.9 ± 0.4 kg (Animal Center of the Fourth Military Medical University, Xi’an, China) were used in this study. Rabbits were acclimatized to the laboratory for 7 days before surgery. All animals were anesthetized via intramuscular injection with 3% pentobarbital sodium (30 mg/kg). Left hindlimbs of rabbits were shaved, cleansed with iodophor solution, and then covered with sterile drapes. A longitudinal incision in the distal femur was placed to expose the lateral condyle. A cylindrical bone defect with 6.0 mm diameter and 8.0 mm length were created with an electrical drill. The drill-hole defect was then washed with saline and hydrogen peroxide, and filled with a matching size cylindrical block of pTi. The incisions in the muscle, subcutaneous tissue and skin were then sutured, respectively. All surgical procedures were performed aseptically to avoid the potential infection of pathogens. At 1 day post surgery, all rabbits were examined using a digital radiography system (Carestream Health DRX-1, Rochester, NY, USA) under anaesthesia with pentobarbital sodium to further confirm the accuracy of the location of bone defect and orientation of pTi implants. Rabbits received intramuscular injection of penicillin (40000 U) for three consecutive days after surgery. One week post surgery, animals were then randomly and equally assigned to the Control and PEMF groups. Rabbits in the PEMF group were subjected to 2 h/day whole-body PEMF stimulation. All animals received intramuscular injections of 8 mg/kg calcein (Sigma) on 14 and 4 days before sacrifice to label mineralizing surfaces for dynamic bone histomorphometric analyses. After PEMF stimulation for 6 and 12 weeks, 6 rabbits in each group were euthanatized with an overdose of pentobarbital sodium. The femoral condylar samples were immediately harvested and immersed in 80% ethanol for μCT, histological and histomorphometric analyses. The femoral bone with 1 cm height right above the bone defect site was snap-frozen in liquid nitrogen for semi-quantitative RT-PCR analyses.

μCT analysis

Left femoral condyles of rabbits in each group (n = 6 femora in each time point) were scanned using a high-resolution μCT system (Y. Cheetah, YXLON, Germany). After scanning, 2-D image sequences were transferred to a workstation and 3-D images were reconstructed with an 18.2 μm isotropic voxel size. A tube volume with 6.0 mm diameter and 8.0 mm length was defined as the volume of interest (VOI), which completely covered the region of the pTi implant. The trabecular bone parameters, including bone volume per total volume (BV/TV), bone surface per bone volume (BS/BV), trabecular number (Tb.N), trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp) were quantified.

Histology and histomorphometry

After μCT scanning, all bone samples were embedded in polymethyl methacrylate. Then, samples were sectioned longitudinally along the pTi implants (~50 μm thick) using the LEICA 2500E diamond saw microtome (Leica SpA, Milan, Italy). The sections were imaged using fluorescence microscope (LEICA DM LA, Leica Microsystems, Heidelberg, Germany) to quantify the dynamic histomorphometric parameters, including mineral apposition rate (MAR, the average distance between the two calcein labels divided by the labeling time intervals), mineralizing surface per bone surface (MS/BS, single-labeled surface plus one half of double-labeled surface in percentage of bone surface) and bone formation rate per bone surface (BFR/BS, calculated as MAR*MS/BS). After calcein double-labeling imaging, samples were subject to Masson-Goldner trichrome staining to further evaluate the cancellous bone histology. The parameter of bone area fraction was quantified from the pixels that represented bone tissue (bone area per total area) in the Masson-Goldner trichrome staining images.

In vivo osteogenesis-related gene expressions

Before RNA extraction, samples were immediately crushed into powder in a mortar containing liquid nitrogen using the pestle and then mixed with the monophasic solution of phenol and guanidine thiocyanate. Total RNA was extracted using the guanidinium isothiocyanate-alcohol phenyl-chloroform method. Then, the FastQuant RT Kit was used to synthesize cDNA from RNA. RT-PCR was performed on the Bio-Rad CFX96 real-time PCR system. The primer sequences utilized in semi-quantitative RT-PCR are shown in Table 2. All mRNA levels were normalized by the house-keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The relative quantity of mRNA was calculated (2−△△Ct analysis).

Table 2. The sequence of primers used in the present study for real-time fluorescence quantitative PCR analysis in rabbit bones.

Genes Primers Primer Sequence (5′-3′) Product Length (bp)
Runx-2 Forward CAGTCTTACCCCTCTTACC 130
Reverse CATCTTTACCTGAAATGCG
BMP2 Forward GGACGACATCCTGAGCGAGT 117
Reverse CGGCGGTACAAGTCCAGCAT
Osteocalcin Forward TTGGTGCACACCTAGCAGAC 216
Reverse ACCTTATTGCCCTCCTGCTT
Wnt1 Forward CTCCACGAACCTGCTAACTG 226
Reverse GACGATCTTGCCGAAGAGG
Lrp6 Forward GCTTGGCACTTGTATGTAAA 179
Reverse TGGGCTAAGATCATCAGACT
β-catenin Forward GACACGGACCACACGCACAA 173
Reverse CCGAGCAGCAGCAAGTCTTCT
GAPDH Forward CATCATCCCTGCCTCCACTG 183
Reverse GATGCCTGCTTCACCACCTT
Open in a new tab

Statistical analysis

All data presented in this study were expressed as the mean ± standard deviation (S.D.). Statistical analyses were performed using SPSS version 13.0 for Windows software (SPSS, Chicago, IL, USA). All data were examined for normal distribution using the Kolmogorov-Smirnov test. The homogeneity of variance was evaluated using the Levene’s test. Analyses showed that each specific parameter for the in vitro or in vivo data obeyed normal distribution and homoscedasticity. For all the in vitro experimental data and in vivo semi-quantitative RT-PCR results, the differences of each parameter between the Control group and PEMF group were examined using a Student t-test. For μCT, histological and histomorphometric analyses, one-way analysis of variance (ANOVA) was employed for evaluating the existence of differences among the four groups, and once a significant difference was observed, Bonferroni’s post hoc analysis was used to determine the significance between each two groups. P < 0.05 was considered statistically significant.

Results

In vitro osteoblast attachment, proliferation and morphology in pTi

As shown in Fig. 2A, PEMF exposure significantly increased cellular attachment for osteoblasts seeded in pTi as compared with the Control group via DAPI staining (P < 0.05). Representative in vitro FITC cytoskeleton staining images of osteoblasts (Fig. 2B) show that cells in the PEMF group displayed well-developed cytoskeleton with higher fluorescence intensity, more microfilaments and thicker stress fibers. In contrast, cells in the Control group showed lower cell number and poorly-organized cytoskeleton. Moreover, statistical comparisons further demonstrate that PEMF stimulation significantly promoted cellular proliferation for osteoblasts seeded in pTi via MTT analyses (Fig. 2C, P < 0.05). SEM scanning shows that cells were proliferated with more pseudopodia in pTi under PEMF stimulation (Fig. 2D). Images with higher magnification reveal that the PEMF-stimulated group shows more ruffled membranes, and more lamellipodia and filopodia as compared with the Control group.

Figure 2. Effects of PEMF exposure on in vitro cellular attachment, proliferation and morphology for osteoblasts seeded in pTi.

Figure 2

Open in a new tab

(A) Comparisons of in vitro osteoblast attachment between the Control and PEMF exposure groups via DAPI staining (n = 15). (B) Representative in vitro FITC cytoskeleton staining images of osteoblasts in the Control and PEMF exposure groups. Scale bar represents 50 μm for all images. (C) Comparisons of in vitro osteoblast proliferation between the Control and PEMF groups via MTT assays (n = 9). MTT was added into in vitro MC3T3-E1 cells to form the formazan, and DMSO was then added to dissolve the formazan. The optical density (OD) values of the mixture were determined at 490 nm with the multimode microplate reader. (D) Representative SEM scanning for in vitro osteoblasts in the Control and PEMF groups. Scale bar represents 10 μm for all images. Values are all expressed as mean ± S.D. *Significant difference from the Control group with P < 0.05.

In vitro osteogenesis-related gene and protein expressions

The results of in vitro osteogenesis-related gene and protein expressions for osteoblasts seeded in pTi are shown in Figs 3 and 4. In comparison with the Control group, PEMF stimulation significantly promoted the expressions of osteogenesis-related genes via semi-quantitative RT-PCR analyses (Fig. 3), including Runx2, Osx and COL-1 (P < 0.05), and also increased the gene expressions of canonical Wnt signaling, including Wnt1, Lrp6 and β-catenin (P < 0.05). The results of western blotting analyses (Fig. 4) reveal that in vitro osteogenesis-related protein expressions for osteoblasts seeded in pTi, including Runx2, Wnt1, Lrp6 and β-catenin were significantly higher in the PEMF-stimulated group than those in the Control group (P < 0.05).

Figure 3. Effects of PEMF exposure on in vitro osteogenesis-related gene expressions for osteoblasts seeded in pTi via semi-quantitative RT-PCR analyses, including Runx2, Osx, COL-1, Wnt1, Lrp6 and β-catenin.

Figure 3

Open in a new tab

Values are all expressed as mean ± S.D. (n = 8 ~ 11) and the relative expression level of each gene was normalized to β-Actin. *Significant difference from the Control group with P < 0.05.

Figure 4. Effects of PEMF exposure on in vitro osteogenesis-related protein expressions for osteoblasts seeded in pTi via western blotting analyses, including Runx2, Wnt1, Lrp6 and β-catenin.

Figure 4

Open in a new tab

Values are all expressed as mean ± S.D. (n = 3 ~ 4). The relative protein expression levels of Runx2 and β-catenin were normalized to β-Actin, and the relative protein expressions of Wnt1 and Lrp6 was normalized to β-Tubulin. *Significant difference from the Control group with P < 0.05.

μCT analysis for in vivo osseointegration of pTi

Representative 3-D and 2-D μCT images for in vivo osseointegration of pTi in the rabbit femora with bone defect are shown in Fig. 5A. As indicated by 3-D μCT images, PEMF exposure for 6 weeks and 12 weeks significantly increased the amount of newly formed bone within the implants as compared with the Control group. Images of 2-D mid-coronal and mid-sagittal slices further confirmed that bone ingrowth through the pores of pTi was significantly promoted by 6-week and 12-week PEMF stimulation. Quantitative statistical comparisons (Fig. 5B) demonstrate that PEMF exposure for 6 weeks and 12 weeks resulted in significant increase of BV/TV (P < 0.05, +78.5% at 6 weeks and +88.0% at 12 weeks). PEMF stimulation for 6 weeks and 12 weeks also significantly decreased the levels of BS/BV (P < 0.05, −36.2% and −43.6%) and Tb.Sp (P < 0.05, −30.7% and −42.8%). Moreover, PEMF exposure caused higher levels of Tb.N at 6 weeks (P > 0.05, +21.7%) and 12 weeks (P < 0.05, +16.3%), and also increased Tb.Th at 6 weeks (P > 0.05, +41.8%) and 12 weeks (P > 0.05, +49.6%). However, no significant difference was observed in BV/TV, BS/BV, Tb.N, Tb.Th and Tb.Sp between 6-week and 12-week PEMF exposure groups (P > 0.05).

Figure 5. Effects of 6-week and 12-week PEMF exposure on the osseointegration of pTi implants in the region of bone defect via μCT scanning.

Figure 5

Open in a new tab

A tube volume with 6.0 mm diameter and 8.0 mm length was defined as the volume of interest (VOI), which completely covered the region of the pTi implant. (A) Reconstructed 3-D μCT images determined by the VOI and 2-D mid-coronal and mid-sagittal slices. The regions with white color represent titanium alloys and the areas with yellow color represent cancellous bones. (B) Quantitative comparisons of μCT characteristic parameters of trabecular bones between the Control and PEMF groups (n = 6), including bone volume per tissue volume (BV/TV), bone surface per bone volume (BS/BV), trabecular number (Tb.N), trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp). Values are all expressed as mean ± S.D. *Significant difference from the Control group at 6 weeks with P < 0.05. #Significant difference from the Control group at 12 weeks with P < 0.05.

Histological and histomorphometric evaluation for in vivo osseointegration of pTi

Representative histological images (Fig. 6A) by Masson-Goldner trichrome staining demonstrate that PEMF exposure stimulated more new trabecular bone ingrowth through the pores of pTi in the region of bone defect. Statistical comparisons of the histological analyses (Fig. 6B) further reveal that the levels of bone area fractions were significantly higher in the PEMF-stimulated group (P < 0.05, +143.1% at 6 weeks and +169.8% at 12 weeks). Dynamic histomorphometric analyses via calcein double-labeling staining (Fig. 7A) show that PEMF stimulation speeded up the new bone formation in the region of bone defect. Quantitative comparisons (Fig. 7B) reveal that 6-week and 12-week PEMF stimulation significantly increased MAR (P < 0.05, +62.7% and +96.3%), MS/BS (P < 0.05, +85.6% and +85.6%) and BFR/BS (P < 0.05, +209.3% and +239.9%) as compared with the Control group. However, no significant difference was found in bone area fraction, MAR, MS/BS and BFR/BS between 6-week and 12-week PEMF exposure groups (P > 0.05).

Figure 6. Effects of 6-week and 12-week PEMF exposure on cancellous bone histology in the region of bone defect via Masson-Goldner trichrome staining.

Figure 6

Open in a new tab

(A) Representative histological images for bone microarchitecture in the region of bone defect by Masson-Goldner trichrome staining. The black areas represent titanium alloys and the red areas represent cancellous bones. Scale bar represents 100 μm for all images. (B) Quantitative comparisons of bone area fraction (bone area per total area) determined by the histological analyses between the Control and PEMF groups (n = 6). Values are all expressed as mean ± S.D. *Significant difference from the Control group at 6 weeks with P < 0.05. #Significant difference from the Control group at 12 weeks with P < 0.05.

Figure 7. Effects of 6-week and 12-week PEMF exposure on dynamic histomorphometric parameters in the region of bone defect via calcein double-labeling analyses.

Figure 7

Open in a new tab

(A) Representative calcein double-labeling sections in the region of bone defect. Scale bar represents 100 μm for all images. (B) Quantitative comparisons of the dynamic histomorphometric parameters, including mineral apposition rate (MAR), mineralizing surface per bone surface (MS/BS) and bone formation rate per bone surface (BFR/BS) between the Control and PEMF groups (n = 6). Values are all expressed as mean ± S.D. *Significant difference from the Control group at 6 weeks with P < 0.05. #Significant difference from the Control group at 12 weeks with P < 0.05.

In vivo osteogenesis-related gene expressions

The results of in vivo osteogenesis-related gene expressions via semi-quantitative RT-PCR analyses are shown in Fig. 8. PEMF exposure for 6 weeks and 12 weeks significantly promoted osteogenesis-related gene expressions as compared with the Control group, including Runx2, BMP2 and OCN (P < 0.05). Moreover, mRNA levels of the canonical Wnt signaling pathway (including Wnt1, Lrp6 and β-catenin) in the PEMF group were also significantly higher than those in the Control group (P < 0.05).

Figure 8. Effects of 6-week and 12-week PEMF exposure on in vivo osteogenesis-related gene expressions in rabbit femora via semi-quantitative RT-PCR analyses, including Runx2, BMP2, OCN, Wnt1, Lrp6 and β-catenin.

Figure 8

Open in a new tab

Values are all expressed as mean ± S.D. (n = 6) and the relative expression level of each gene was normalized to GAPDH. *Significant difference from the Control group with P < 0.05.

Discussion

Titanium alloys especially at porous structures have shown great potential for the application in orthopedics. Exploring effective approaches for enhancing the repair efficiency and quality of titanium implants in bone defect remain critical and significant clinical topics. In the present study, PEMF exposure, as a kind of safe and non-contact biophysical intervention, was employed to determine its capacity for improving the osseointegrative properties of pTi implants. Our findings clearly demonstrate that PEMF stimulation significantly promoted osteoblast functions and activities in pTi in vitro and enhanced osteogenesis and bone ingrowth of pTi implants in vivo in bone defect animals. Moreover, we also reveal that canonical Wnt signaling might be involved in the promotion of osseointegration of pTi implants by PEMF stimulation. Our findings suggest that PEMF might become a potential biophysical modality for enhancing the repair efficiency and quality of pTi implants in bone defect.

The spatial magnetic action and electric currents are able to be generated surrounding the bone tissues when the skeletons are exposed to exogenous PEMF stimulation. Titanium implants, as typical nonferromagnetic materials, possess excellent properties of electrical conduction, but not disturb or shield the spatial magnetic flux distribution34,35. Thus, the favorable electromagnetic compatibility of titanium implants provides theoretical feasibility for the combined pTi and PEMF therapy for bone defect. In the present study, the structural parameters of pTi, including the porosity and pore size have been widely used in previous investigations both experimentally and clinically7,36,37. Our μCT and histological staining results reveal the limited bone ingrowth through the pores 7 weeks and 13 weeks post surgery, which necessitate the treatment for the enhancement of osseointegration of pTi. In the group receiving PEMF exposure, more new trabecular bone formation was observed at the implant-bone interface as well as in the center of the implants, as evidenced by the μCT and static histomorphometric results. Our findings revealed faster and higher-quality osseointegration under the PEMF exposure, which may lead to long-term stability and durability of implant fixation, as well as better overall mechanical performance of whole bone38,39. Furthermore, calcein double labeling-based histomorphometric analyses were used to evaluate the effects of PEMF on bone remodeling in pTi implants. Our dynamic bone histomorphometric results demonstrate the modulating role of PEMF in bone remodeling with obvious anabolic effects at the bone defect site. PEMF exposure significantly increased the bone formation rate in pTi implants, as revealed by increased MAR, MS/BS and BFR/BS. These results keep consistent with our previous findings for the regulatory role of PEMF in bone metabolism in osteoporotic rats20. However, we did not observe significant difference in μCT, histological and histomorphometric parameters between 6-week and 12-week PEMF exposure, indicating that 6-week PEMF stimulation may provide adequate osseointegration and bone ingrowth of pTi implants. Moreover, our PCR results further demonstrate that PEMF exposure significantly promoted in vivo gene expressions of Runx2, BMP2 and OCN, revealing obvious promotive effects of PEMF on osteoblastogenesis in peri-implant bones40. Taken together, our in vivo results show that PEMF stimulation has the capacity of enhancing bone ingrowth and osseointegration in pTi implants by promoting bone anabolism.

To further examine the promotional effects of PEMF exposure on the biocompatibility of pTi with bone cells, in vitro osteoblasts seeded into three-dimensional pTi discs were subjected to PEMF stimulation with the same parameters as the in vivo investigation. Our results demonstrate that PEMF stimulation enhanced the proliferation of osteoblasts in vitro in three-dimensional pTi during the cellular active proliferation stage via MTT and fluorescence staining observations, which keep consistent with previous studies on monolayer cells24,41 or cells seeded on two-dimensional flat titanium surface27. Our findings also reveal that PEMF stimulation facilitated the initial adhesion of osteoblasts to pTi. The potential mechanism might be associated with the polarization of cell membrane and increased protein adsorption to the pTi surface induced by the electrical potential generated by PEMF27,42. Besides the increased cell amount, osteoblasts in pTi also exhibited significantly distinct microstructure and cytoskeletal organization after PEMF simulation. Cells in the PEMF group exhibited more ruffled membranes and many more pseudopodia and microfilaments. These changes in cellular structures were considered to be essential events for bone cells detecting and transducing the external biophysical signals, and thus regulating the biological behavior of bone cells (e.g., proliferation and differentiation)43,44,45. Moreover, our findings also showed significantly up-regulated expressions of biomarkers for osteoblast differentiation and mineralization (Runx2, Osx and COL-1) in PEMF-stimulated group40,46,47, revealing the potential stimulatory efficiency of PEMF on osteogenesis for osteoblasts in vitro seeded in pTi. Thus, our findings suggest that PEMF stimulation was able to promote the biological activities and functions of in vitro osteoblasts in three-dimensional pTi implants.

To unravel the mechanism by which PEMF exposure modulated osseointegration and bone remodeling in pTi implants, gene expressions of osteoblastogenesis-associated canonical Wnt signaling pathway were systematically investigated both in vivo and in vitro. Wnts, as a family of secreted proteins existing extensively within the skeleton, can bind to the cell membrane Frizzled and Lrp5/6 co-receptors, and consequently lead to the stabilization of β-catenin in the cytoplasm and promote more Wnt-targeted gene transcription48,49. Activation of canonical Wnt signaling can increase bone formation via multiple routes, including promoting the differentiation of mesenchymal stem cells into mature osteoblasts, enhancing the proliferation and mineralization of osteoblasts, and preventing the osteoblast apoptosis49. A large body of evidence has also revealed the importance of canonical Wnt signaling in regulating the expressions of osteogenesis-related cytokines50,51,52. Zhang and colleagues found that Wnt/β-catenin signaling was able to activate BMP2 gene expressions of osteoblasts53. Studies by Gaur et al. have also shown that canonical Wnt signaling promotes osteogenesis by directly stimulating Runx2 gene expression both in vitro and in vivo54. It has also been shown that Wnts have the capacity of up-regulating the expression of Osx55. In the present study, our semi-quantitative RT-PCR and western blotting results demonstrate significant increases of gene and protein expressions of canonical Wnt signaling for in vitro osteoblasts seeded in pTi in PEMF-stimulated group, including Wnt1, Lrp6 and β-catenin. Moreover, our findings also reveal that PEMF augmented the in vivo gene expressions of Wnt1, Lrp6 and β-catenin of peri-implant bones, revealing that canonical Wnt signaling has been implicated in regulating PEMF-induced improvement of osteogenesis in pTi implants in the repair of bone defect. These findings keep consistent with in vivo findings, revealing PEMF-induced activation of canonical Wnt signaling in osteoporotic rats20,32,56. Together, our results indicate that PEMF might regulate osteoblastogenesis and new bone formation in pTi implants through a potentially primary mechanism of promoting the activation of canonical Wnt signaling.

There are also some limitations in the present study. First, our in vitro experiment was performed on murine-derived MC3T3-E1 osteoblast cell line, which was different with the animal species used for our in vivo investigation. However, our findings reveal PEMF-induced enhancement on the biological activities of mouse MC3T3-E1 cells in vitro and bone ingrowth of pTi in rabbit bone defect in vivo, confirming the positive efficiency of PEMF on osteogenesis and osseointegration of pTi. Second, our present in vivo experimental technique was still unable to fully elucidate the cellular microenvironment mechanism for PEMF-induced acceleration of osteogenesis and osseointegration surrounding the implant. Osetoblasts, osteoclasts and macrophages as well as mesenchymal and hematopoietic stem cells may be all involved in this process of osseointegration. This issue will be systematically clarified in the following in vivo investigations. Third, we herein created the cylindrical bone defect in the femoral lateral condyle. The reason for selecting this region as the defect site is that it contains abundant trabecular bone which is much easier to investigate and quantify osteogenesis and bone ingrowth of pTi. However, it should be noted that most posttraumatic defects occur in the diaphysis. Thus, investigating the effects of PEMF on osseointegration of pTi in the diaphyseal cortical bone will be also an interesting and important aspect in the succeeding study.

Conclusion

In conclusion, the present study represents the first report demonstrating that PEMF stimulation promoted bone ingrowth and osseointegration of pTi implants via obvious anabolic actions in the repair of bone defect. Our findings also reveal significantly beneficial effects of PEMF exposure on the biological activities and functions of in vitro osteoblasts seeded in pTi implants. Moreover, activation of Wnt1, Lrp6 and β-catenin was observed both in vitro and in vivo in PEMF-stimulated group, revealing the involvement of canonical Wnt signaling in promoting osteogenesis in pTi implants. Our findings suggest that pTi implants accompanied by PEMF exposure exhibit high efficiency and quality in the repair of bone defect, and might become a clinically applicable treatment modality for osseous defects.

Additional Information

How to cite this article: Jing. et al. Pulsed electromagnetic fields promote osteogenesis and osseointegration of porous titanium implants in bone defect repair through a Wnt/β-catenin signaling-associated mechanism. Sci. Rep. 6, 32045; doi: 10.1038/srep32045 (2016).

Acknowledgments

The authors acknowledge the support from the National Natural Science Foundation of China (Nos 81471806, 31500760 and 31270889).

Footnotes

Author Contributions All authors contributed to the manuscript. D.J., X.K.L. and E.P.L. designed research. D.J., M.M.Z., F.X., S.C.T., J.C., Y.W., Q.L.X. and K.N.X. performed research. D.J., M.M.Z., S.C.T., G.H.S., Q.L.X., J.L., Q.L.X. and E.P.L. analyzed data. D.J. and M.M.Z. wrote the paper. D.J., Q.L.X. and E.P.L. revised the manuscript. All authors reviewed the manuscript. D.J. and M.M.Z. are co-first authors.

References

  1. Calori G. M., Mazza E., Colombo M. & Ripamonti C. The use of bone-graft substitutes in large bone defects: any specific needs? Injury 42 Suppl 2, S56–S63 (2011). [DOI] [PubMed] [Google Scholar]
  2. Bauer T. W. & Muschler G. F. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 10–27 (2000). [PubMed] [Google Scholar]
  3. Gazdag A. R., Lane J. M., Glaser D. & Forster R. A. Alternatives to Autogenous Bone Graft: Efficacy and Indications. J Am Acad Orthop Surg 3, 1–8 (1995). [DOI] [PubMed] [Google Scholar]
  4. Delloye C., Cornu O., Druez V. & Barbier O. Bone allografts: What they can offer and what they cannot. J Bone Joint Surg Br 89, 574–579 (2007). [DOI] [PubMed] [Google Scholar]
  5. Bonfield W., Wang M. & Tanner K. E. Interfaces in analogue biomaterials. Acta Mater 46, 2509–2518 (1998). [Google Scholar]
  6. Bandyopadhyay A. et al. Influence of porosity on mechanical properties and in vivo response of Ti6Al4V implants. Acta Biomater 6, 1640–1648 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Li X. K. et al. The treatment effect of porous titanium alloy rod on the early stage talar osteonecrosis of sheep. PLoS One 8, e58459 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ryan G., Pandit A. & Apatsidis D. P. Fabrication methods of porous metals for use in orthopaedic applications. Biomaterials 27, 2651–2670 (2006). [DOI] [PubMed] [Google Scholar]
  9. Liang B. et al. Histological and mechanical investigation of the bone-bonding ability of anodically oxidized titanium in rabbits. Biomaterials 24, 4959–4966 (2003). [DOI] [PubMed] [Google Scholar]
  10. Le Guehennec L., Soueidan A., Layrolle P. & Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater 23, 844–854 (2007). [DOI] [PubMed] [Google Scholar]
  11. Nayak S., Dey T., Naskar D. & Kundu S. C. The promotion of osseointegration of titanium surfaces by coating with silk protein sericin. Biomaterials 34, 2855–2864 (2013). [DOI] [PubMed] [Google Scholar]
  12. Bassett C. A., Mitchell S. N. & Gaston S. R. Pulsing electromagnetic field treatment in ununited fractures and failed arthrodeses. JAMA 247, 623–628 (1982). [PubMed] [Google Scholar]
  13. Assiotis A., Sachinis N. P. & Chalidis B. E. Pulsed electromagnetic fields for the treatment of tibial delayed unions and nonunions. A prospective clinical study and review of the literature. J Orthop Surg Res 7, 24 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ryang We, S., Koog Y. H., Jeong K. I. & Wi H. Effects of pulsed electromagnetic field on knee osteoarthritis: a systematic review. Rheumatology (Oxford) 52, 815–824 (2013). [DOI] [PubMed] [Google Scholar]
  15. Chang K. & Chang W. H. Pulsed electromagnetic fields prevent osteoporosis in an ovariectomized female rat model: a prostaglandin E2-associated process. Bioelectromagnetics 24, 189–198 (2003). [DOI] [PubMed] [Google Scholar]
  16. Rubin C. T., McLeod K. J. & Lanyon L. E. Prevention of osteoporosis by pulsed electromagnetic fields. J Bone Joint Surg Am 71, 411–417 (1989). [PubMed] [Google Scholar]
  17. Sert C., Mustafa D., Duz M. Z., Aksen F. & Kaya A. The preventive effect on bone loss of 50-Hz, 1-mT electromagnetic field in ovariectomized rats. J Bone Miner Metab 20, 345–349 (2002). [DOI] [PubMed] [Google Scholar]
  18. Jing D. et al. The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats. Osteoporos Int 22, 1885–1895 (2011). [DOI] [PubMed] [Google Scholar]
  19. Jing D. et al. Circadian rhythm affects the preventive role of pulsed electromagnetic fields on ovariectomy-induced osteoporosis in rats. Bone 46, 487–495 (2010). [DOI] [PubMed] [Google Scholar]
  20. Jing D. et al. Pulsed Electromagnetic Fields Partially Preserve Bone Mass, Microarchitecture, and Strength by Promoting Bone Formation in Hindlimb-Suspended Rats. J Bone Miner Res (2014). [DOI] [PubMed] [Google Scholar]
  21. Tabrah F., Hoffmeier M., Gilbert F. Jr., Batkin S. & Bassett C. A. Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs). J Bone Miner Res 5, 437–442 (1990). [DOI] [PubMed] [Google Scholar]
  22. Eyres K. S., Saleh M. & Kanis J. A. Effect of pulsed electromagnetic fields on bone formation and bone loss during limb lengthening. Bone 18, 505–509 (1996). [DOI] [PubMed] [Google Scholar]
  23. Bodamyali T. et al. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun 250, 458–461 (1998). [DOI] [PubMed] [Google Scholar]
  24. Diniz P., Shomura K., Soejima K. & Ito G. Effects of pulsed electromagnetic field (PEMF) stimulation on bone tissue like formation are dependent on the maturation stages of the osteoblasts. Bioelectromagnetics 23, 398–405 (2002). [DOI] [PubMed] [Google Scholar]
  25. Chang K., Chang W. H., Huang S. & Shih C. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor. J Orthop Res 23, 1308–1314 (2005). [DOI] [PubMed] [Google Scholar]
  26. Chang K., Hong-Shong Chang W., Yu Y. H. & Shih C. Pulsed electromagnetic field stimulation of bone marrow cells derived from ovariectomized rats affects osteoclast formation and local factor production. Bioelectromagnetics 25, 134–141 (2004). [DOI] [PubMed] [Google Scholar]
  27. Wang J. et al. The effects of pulsed electromagnetic field on the functions of osteoblasts on implant surfaces with different topographies. Acta Biomater 10, 975–985 (2014). [DOI] [PubMed] [Google Scholar]
  28. Atalay B. et al. The effects of pulsed electromagnetic field (PEMF) on osteoblast-like cells cultured on titanium and titanium-zirconium surfaces. J Craniofac Surg 24, 2127–2134 (2013). [DOI] [PubMed] [Google Scholar]
  29. Grana D. R., Marcos H. J. & Kokubu G. A. Pulsed electromagnetic fields as adjuvant therapy in bone healing and peri-implant bone formation: an experimental study in rats. Acta Odontol Latinoam 21, 77–83 (2008). [PubMed] [Google Scholar]
  30. Matsumoto H. et al. Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits. Clin Oral Implants Res 11, 354–360 (2000). [DOI] [PubMed] [Google Scholar]
  31. Akca K. et al. Micro-morphologic changes around biophysically-stimulated titanium implants in ovariectomized rats. Head Face Med 3, 28 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Jing D. et al. Pulsed electromagnetic fields improve bone microstructure and strength in ovariectomized rats through a Wnt/Lrp5/beta-catenin signaling-associated mechanism. PLoS One 8, e79377 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wang J., She S. & Zhang S. An improved Helmholtz coil and analysis of its magnetic field homogeneity. Rev Sci Instrum 73, 2175–2179 (2002). [Google Scholar]
  34. Hayes J. S. & Richards R. G. The use of titanium and stainless steel in fracture fixation. Expert Rev Med Devices 7, 843–853 (2010). [DOI] [PubMed] [Google Scholar]
  35. Martin A. D., Driscoll C. L., Wood C. P. & Felmlee J. P. Safety evaluation of titanium middle ear prostheses at 3.0 tesla. Otolaryngol Head Neck Surg 132, 537–542 (2005). [DOI] [PubMed] [Google Scholar]
  36. Dabrowski B., Swieszkowski W., Godlinski D. & Kurzydlowski K. J. Highly porous titanium scaffolds for orthopaedic applications. J Biomed Mater Res B Appl Biomater 95, 53–61 (2010). [DOI] [PubMed] [Google Scholar]
  37. Karageorgiou V. & Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474–5491 (2005). [DOI] [PubMed] [Google Scholar]
  38. Mavrogenis A. F., Dimitriou R., Parvizi J. & Babis G. C. Biology of implant osseointegration. J Musculoskelet Neuronal Interact 9, 61–71 (2009). [PubMed] [Google Scholar]
  39. Goodman S. B., Yao Z., Keeney M. & Yang F. The future of biologic coatings for orthopaedic implants. Biomaterials 34, 3174–3183 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Harada S. & Rodan G. A. Control of osteoblast function and regulation of bone mass. Nature 423, 349–355 (2003). [DOI] [PubMed] [Google Scholar]
  41. Chang W. H., Chen L. T., Sun J. S. & Lin F. H. Effect of pulse-burst electromagnetic field stimulation on osteoblast cell activities. Bioelectromagnetics 25, 457–465 (2004). [DOI] [PubMed] [Google Scholar]
  42. Funk R. H. & Monsees T. K. Effects of electromagnetic fields on cells: physiological and therapeutical approaches and molecular mechanisms of interaction. A review. Cells Tissues Organs 182, 59–78 (2006). [DOI] [PubMed] [Google Scholar]
  43. Huang H., Kamm R. D. & Lee R. T. Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am J Physiol Cell Physiol 287, C1–11 (2004). [DOI] [PubMed] [Google Scholar]
  44. Klein-Nulend J., Bacabac R. G. & Bakker A. D. Mechanical loading and how it affects bone cells: the role of the osteocyte cytoskeleton in maintaining our skeleton. Eur Cell Mater 24, 278–291 (2012). [DOI] [PubMed] [Google Scholar]
  45. Titushkin I. & Cho M. Regulation of cell cytoskeleton and membrane mechanics by electric field: role of linker proteins. Biophys J 96, 717–728 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Franceschi R. T. & Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88, 446–454 (2003). [DOI] [PubMed] [Google Scholar]
  47. Franceschi R. T. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 10, 40–57 (1999). [DOI] [PubMed] [Google Scholar]
  48. Baron R. & Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19, 179–192 (2013). [DOI] [PubMed] [Google Scholar]
  49. Krishnan V., Bryant H. U. & Macdougald O. A. Regulation of bone mass by Wnt signaling. J Clin Invest 116, 1202–1209 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9, 183–196 (2008). [DOI] [PubMed] [Google Scholar]
  51. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 13, 27–38 (2012). [DOI] [PubMed] [Google Scholar]
  52. Osta B., Benedetti G. & Miossec P. Classical and Paradoxical Effects of TNF-alpha on Bone Homeostasis. Front Immunol 5, 48 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhang R. et al. Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52, 145–156 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Gaur T. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280, 33132–33140 (2005). [DOI] [PubMed] [Google Scholar]
  55. Bennett C. N. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102, 3324–3329 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zhou J. et al. Effects of pulsed electromagnetic fields on bone mass and Wnt/beta-catenin signaling pathway in ovariectomized rats. Arch Med Res 43, 274–282 (2012). [DOI] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES